Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Apr 1, 2024
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2024Buy(P)2K$1.06$2K770K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-24-005796) within minutes of acceptance. Every field above traces to the original document. Verify it directly: